ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000234567.1	ABT-263 (navitoclax)	Skin cutaneous melanoma	0.026287045	Resistant
ENSG00000234567.1	ABT-263 (navitoclax)	Liver hepatocellular carcinoma	0.009955022	Sensitive